Home » Topics » BioWorld Science

BioWorld Science
RSS

Palatin receives FDA clearance to start LeuTech clinical trials

Nov. 24, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

NK3 antagonist demonstrates intestinal antiinflammatory activity

Nov. 24, 1997

FDA advisory committee recommends approval of Rocephin for AOM

Nov. 24, 1997

Role of substance P in PTH secretion described

Nov. 24, 1997

New NK1 antagonist from Novartis

Nov. 24, 1997

Six-month trial of lamivudine for chronic hepatitis B

Nov. 24, 1997

Phase I trial of multiple-dose IDEC-C2B8 in NHL

Nov. 24, 1997

Role of complement in mast cell-dependent natural immunity

Nov. 24, 1997

Favorable results obtained in pediatric study of Neuprex

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...